Two regulatory regimes — SEBI and IBC — running in parallel, with conflicting timelines and overlapping disclosure obligations. Specialist coordination is the only way through.
When a listed company enters the corporate insolvency resolution process (CIRP) under the Insolvency and Bankruptcy Code, two regulatory worlds collide. The Resolution Professional takes operational control while LODR compliance continues. The Committee of Creditors drives the resolution timeline while market disclosures continue uninterrupted. Promoter rights compress dramatically. Equity value depends entirely on the eventual resolution plan. This is the most complex listed-company scenario — and it requires specialist advisory that understands both regimes.
Despite CIRP, the company remains listed. All material event disclosures, financial result filings, and shareholder communications continue — now signed by the RP rather than the board.
Promoters lose operational control to the RP. Board powers are suspended. Voting rights at AGMs may be restricted. The 29A bar may prevent participation in resolution.
Resolution plans frequently extinguish existing equity entirely. Promoter and public shareholding can both go to zero. Some plans preserve minority equity; most do not.
A successful resolution often involves the resolution applicant taking the company forward — with a fresh listing event, shareholder approvals, and SEBI clearances all in parallel.
Promoters are generally barred by Section 29A from submitting a resolution plan for their own company. But they retain rights — to defend pre-CIRP transactions, to participate in stakeholder consultations, to protect minority equity where possible, and to negotiate post-resolution scenarios. Strategic promoter advisory during CIRP can materially influence outcomes, especially in cases where the resolution plan preserves some equity continuity or where the company exits CIRP without a successful resolution.
A sequenced four-step engagement built around the specific regulatory profile of your category. Modular, stage-wise, and promoter-friendly.
If any of these sound familiar, the situation is more common than you think — and the pathway is well-defined.
A confidential diagnostic call with our R3 team. We'll walk through your case, indicate revival or resolution feasibility, and outline the realistic next step. No fee, no commitment.